CD44 and T-cell acute lymphoblastic leukemia: In a previous study performed on T-cell acute lymphoblastic leukemia (TALL) mice, it has been shown that CD44 knock-down augmented chemosensitivity to doxorubicin and dexamethasone, suggesting that CD44 is involved in drug resistance in TALL (44).